Olaratumab - Eli Lilly and Company
At a glance
- Drug Originator ImClone Systems
- Drug Class Antineoplastics; Immunotherapies; Monoclonal antibodies
- Mechanism of Action Platelet-derived growth factor alpha receptor antagonists
- USA Patent Applicants ELI LILLY AND CO
- USA Patents 21
- BLAs 1
- International Patents 163
Disclaimer